Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $133.6000 (0.79%) ($131.6800 - $134.3100) on Mon. Jul. 25, 2016. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.89% (three month average) | RSI | 69 | Latest Price | $133.6000(0.79%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND advances 1.2% a day on average for past five trading days. | Weekly Trend | LGND advances 3.1% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Normal for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(58%) IWO(56%) XBI(56%) IWC(52%) ARKG(51%) | Factors Impacting LGND price | LGND will decline at least -0.945% in a week (0% probabilities). VIXM(-15%) TLT(-15%) UUP(-8%) GDXJ(-5%) IPO(-4%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.945% (StdDev 1.89%) | Hourly BBV | 0 () | Intraday Trend | 0.6% | | | |
|
5 Day Moving Average | $132.26(1.01%) | 10 Day Moving Average | $129.69(3.01%) | 20 Day Moving Average | $125.9(6.12%) | To recent high | -1.1% | To recent low | 19.5% | Market Cap | $2.147b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |